Dr. Joshua D Mitchell, M.D., FACC
Claim this profileWashington University School of Medicine
Studies Breast Cancer
Studies Torsade de Pointes
4 reported clinical trials
4 drugs studied
Affiliated Hospitals
Clinical Trials Joshua D Mitchell, M.D., FACC is currently running
Continuous Cardiac Monitoring
for Heart Arrhythmia
This trial aims to test a small, wearable patch that continuously monitors heart activity. It focuses on patients taking medications that could lead to heart problems. The goal is to see if this patch is as effective as standard heart monitoring methods like electrocardiograms (ECGs).
Recruiting1 award N/A
Carvedilol
for Cardiomyopathy in Breast Cancer Patients
Breast cancer patients undergoing trastuzumab-based HER2-directed therapy are at risk of heart function decline or heart failure symptoms, but it is unknown if, when, and for how long cardiovascular protective strategies, e.g. with a beta-blocker, could help. This study randomly assigns those taking curative-intent trastuzumab-based HER2-directed therapy to the beta-blocker carvedilol-either when significant heart function decline or subtle early signs of heart injury (either by elevation of a cardiac blood biomarker, i.e. cardiac troponin, or by an abnormal heart ultrasound marker, i.e. global longitudinal strain) are noted, or preventatively before beginning trastuzumab-based HER2-directed therapy. This study will further randomly assign those patients on carvedilol to either discontinuation at the end of trastuzumab-based HER2-directed therapy or continuation for another year, providing much needed clinical trial data on what the best strategy ("tactic") for those at risk of cardiotoxicity with trastuzumab-based HER2-directed therapy is.
Recruiting1 award Phase 23 criteria
More about Joshua D Mitchell, M.D., FACC
Clinical Trial Related4 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Joshua D Mitchell, M.D., FACC has experience with
- BodyGuardian Heart
- Carvedilol
- Intensive Blood Pressure Management
- Home-based Cardiac Rehabilitation
Breakdown of trials Joshua D Mitchell, M.D., FACC has run
Breast Cancer
Torsade de Pointes
Long QT Syndrome
Torsades de Pointes
Medullary Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Joshua D Mitchell, M.D., FACC specialize in?
Joshua D Mitchell, M.D., FACC focuses on Breast Cancer and Torsade de Pointes. In particular, much of their work with Breast Cancer has involved HER2 positive patients, or patients who are undergoing treatment.
Is Joshua D Mitchell, M.D., FACC currently recruiting for clinical trials?
Yes, Joshua D Mitchell, M.D., FACC is currently recruiting for 2 clinical trials in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that Joshua D Mitchell, M.D., FACC has studied deeply?
Yes, Joshua D Mitchell, M.D., FACC has studied treatments such as BodyGuardian Heart, Carvedilol, Intensive Blood Pressure Management.
What is the best way to schedule an appointment with Joshua D Mitchell, M.D., FACC?
Apply for one of the trials that Joshua D Mitchell, M.D., FACC is conducting.
What is the office address of Joshua D Mitchell, M.D., FACC?
The office of Joshua D Mitchell, M.D., FACC is located at: Washington University School of Medicine, Saint Louis, Missouri 63110 United States. This is the address for their practice at the Washington University School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.